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Background
The mammalian oocyte is a unique cell because it exhibits high transcriptional activity during growth, followed by transcriptional quiescence when it is stimulated to resume meiosis [1] [2] [3] .
The oocyte then relies on a pool of previously transcribed and stored RNA to maintain cellular processes through fertilization and activation of the embryonic genome. Post-transcriptional gene regulation and translational control have increased importance in oocytes and are essential to generate high quality female gametes [4, 5] .
Comparison of RNA-seq datasets to genomic sequences has led to the realization that RNA editing is a widespread mechanism of post-transcriptional gene regulation [6] . RNA editing can affect both non-coding and coding regions of transcripts by altering splice acceptor sites, RNA secondary structure, recognition motifs in 5' and 3'UTR, as well as codon sequences [7] . The result of RNA editing can impact transcript abundance, increase proteome diversity, and prevent detection of cellular RNA as foreign [8] [9] [10] [11] [12] [13] [14] [15] [16] . A common form of RNA editing is deamination of adenosines into inosines (A-to-I). This is carried out by adenosine deaminases acting on RNA (ADARs), a family of dsRNA binding proteins [17, 18] . ADARs deaminate both inter-and intramolecular dsRNA of more than 20 base pairs in length [19] , and are conserved in metazoans [20] .
Mammals have three ADAR genes: Adar , Adarb1 , and Adarb2 , encoding the proteins ADAR1, ADAR2, and ADAR3, respectively [8] . ADAR1 and ADAR2 are enzymatically active and are known to edit dsRNA, whereas ADAR3 has no reported enzymatic activity. ADAR1 is ubiquitously expressed in tissues, while ADAR2 is expressed predominantly in the brain [21, 22] .
In addition to the three ADARs, another family of adenosine deaminases (testis nuclear RNA-binding protein TENR, also known as ADAD1), and TENR-like (TENRL, also known as ADAD2) have a similar structure to ADAR, but no deaminase activity due to the lack of a portion of the deaminase domain [23, 24] . Deletion of ADAR1 in mice results in embryonically lethality due to defective organ development coupled with a systemic interferon response [12, [25] [26] [27] [28] .
ADAR2 knockout mice die before postnatal day 20 due to unedited Gria2 in neurons [29] . While ADAR2 has a defined molecular mechanism of action primarily in neurons, ADAR1 likely has a larger pool of edited substrates and a prominent role in post-transcriptional gene regulation in a variety of cell types.
Post-transcriptional events such as RNA editing are transient due to the rapid turnover of mRNA messages. Typically, in order to study post-transcriptional events in the absence of transcription, extra-physiological methodologies, such as chemical blockers or genetic manipulation, are necessary to dissect the molecular mechanisms [30] [31] [32] . To avoid this limitation, we studied RNA editing under a normal physiological condition in which transcription is naturally arrested. We utilized mouse oogenesis as model to study RNA editing due to the natural transcriptional quiescence that occurs during the later stages of oogenesis and maturation. In the current studies, we identified a previously unreported RNA editing phenomenon that has the potential to alter codon usage and affect mRNA stability and translation.
Results

ADAR expression and localization during mouse oogenesis
To dissect the role of RNA editing in mouse oocytes, we assessed transcript abundance of adenosine deaminases in growing PND12 oocytes, fully grown GV oocytes, and MII eggs.
Globally, we observed that the three stages of oogenesis are transcriptionally distinct (Supplemental Fig 1a) . We identified Adar (ADAR1) as the only adenosine deaminase with significant differential transcript abundance (Fig 1a, Supplemental Fig 1b-f) . In mice, Adar generates three mRNA isoforms (Supplemental Fig 2) . Transcript variant 3 (NM_001146296) encodes the longest ADAR1 protein, ADAR1 p150 ( Supplemental Fig 2c) . Transcript variant 1 (NM_019655) is similar to Variant 3, except for an alternative splicing event that shortens the 3' end of exon 7 by 26 amino acids ( Supplemental Fig 2b-c) . ADAR1 p110 is encoded by transcript variant 2 (NM_001038587), generated from an alternative promoter within intron 1 ( Supplemental Fig 2a) . The remaining adenosine deaminases, Adarb1 (ADAR2), Adarb2 (ADAR3), and adenosine deaminase domain containing 2 ( Adad2) exhibited low expression, while Adad1 was undetectable ( Supplementary Fig 1b-f ).
Growing oocytes from PND12 mice expressed very low levels of transcripts encoding the ADAR1 p110 isoform (Fig 1a-c) . Conversely, fully grown GV oocytes contained high levels of variant 2, which then decreased by the MII stage (Fig 1c) . Neither of the transcripts encoding the larger ADAR1 p150 proteins showed statistical differences across the three stages of development (Fig 1a-b) . Transcript variant 1 lacking a portion of exon 7 was present at higher levels in oocytes than transcript variant 3 (Fig 1b) . Functional differences between transcript variant 1 and 3 are unknown, but the dsRNA binding domains and deaminase domain are identical ( Supplemental Fig 2c) . Abundant ADAR1 p110 protein levels were observed in GV oocytes and MII eggs (Fig 1d) , with none detected in the growing PND12 oocytes. Additionally, we were unable to detect the p150 isoform of the protein (Fig 1d) . These results indicate that Adar /ADAR1 is most abundant in transcriptionally inactive fully grown GV oocytes and MII eggs.
Identification and validation of RNA edits in mouse oocytes
The differential expression of Adar in mouse oocytes and eggs led us to analyze global A-to-I editing during mouse oogenesis. We utilized the Genome Analysis Toolkit (GATK) pipeline for calling variants in RNA-seq data, with modifications [33] . We identified putative A-to-I RNA edits in pools of PND12 oocytes (n=3), GV oocytes (n=3), and MII eggs (n=7). Because growing PND12 oocytes had minimal levels of ADAR1, we expected minimal A-to-I editing to occur in these samples. Indeed, significantly fewer A-to-I RNA edited transcripts were observed in PND12 oocytes (733 ± 49 edited transcripts/sample; Mean ± SEM) than in GV oocytes (3,207 ± 117) and MII eggs (3,003 ± 290; p<0.05, one-way ANOVA; Fig 2a) . RNA editing was validated in three identified genes (RPA1, MDC1, and WDR37) using Sanger sequencing of cDNA and genomic DNA derived from GV oocytes of wild-type C57BL/6J female mice (Fig 2b) . We were able to successfully verify RNA editing in all three genes, as indicated by the appearance of A-to-G transitions on the forward cDNA strand, or C-to-T transitions on the reverse cDNA strand (Fig 2b) .
It is possible that the ~4-fold increase in number of edited transcripts seen in GV oocytes and MII eggs represents a stabilized population of transcripts that are not present in PND12 oocytes, rather than due to ADAR1 activity. To test this, we measured transcript abundance between PND12 oocytes, GV oocytes, and MII eggs. We measured transcript abundance by aligning raw RNA-seq reads to the mouse RefSeq database which includes over 30,000 unique transcripts (See Methods). We observed that the total number of unique transcripts detected in GV oocytes and MII eggs was 30% greater than in PND12 oocytes (Fig 2c) . An assessment of RNA editing in transcripts that were commonly present at all three stages of oogenesis (Fig 2d) was completed to account for increased transcript abundance observed in the later stage oocytes.
Within the pool of common transcripts, we observed a ~4-fold increase in the number of edited transcripts in GV oocytes and MII eggs (Fig 2d) . These results indicate that the increase in RNA editing observed in GV oocytes and MII eggs is not due to the overall amount of transcripts present, but is strongly correlated with oocyte ADAR1 abundance (Fig 1c-d) .
Oocyte-specific pattern of RNA editing
In addition to having the fewest edited transcripts, PND12 oocytes had the lowest proportion of the transcriptome that was edited (7.8 ± 0.2%; Mean ± SEM), compared to GV oocytes (26.3 ± 0.9%) and MII eggs (25.6 ± 2.6%; Fig 3a) . The proportion of edited transcripts in oocytes was similar to mouse somatic tissues (colon, heart, large intestine, and stomach) from wild-type mice, except for the brain, which has a higher percentage of A-to-I edits ( Supplemental Fig 3a) .
Consistent with higher levels of ADAR1 protein, GV oocytes and MII eggs have an approximately 2-fold increase in the number of RNA edits per transcript compared to PND12 oocytes (Fig 3b) . We did not observe a difference in the number of edits per transcript among somatic tissues that express other ADAR genes (Supplemental Fig 3b and Supplemental Fig 4 ) .
To further characterize the nature of RNA edits in oocytes, we determined the location of edits within protein-coding genes by annotating the location of each edit (5'UTR, coding, intron, and 3'UTR). Overall, the distribution of edits is similar between all stages of oogenesis, however, compared to somatic tissue, the oocyte has a unique pattern of RNA editing (Fig 3c and Fig 3d) .
Mouse oocytes display a higher proportion of coding region (CDS) edits compared to mouse somatic tissue (Fig 3c and Fig 3d) , indicating that RNA editing in mouse oocytes may be fundamentally different.
Consequences of coding sequence RNA edits in mouse oocytes
To understand the consequence of RNA editing, if any, on the protein coding capacity of edited GV and MII mRNA transcripts, we used Ensembl Variant Effect Predictor (VEP) [34] to identify the synonymous and nonsynonymous substitutions (Fig 4a) . Among the nonsynonymous substitutions, altered stop codons (stop loss, stop gain, or stop retained) made up less than 0.3% of coding sequence edits. Therefore, stop codon substitutions were not included in further analyses. We found a significant increase in synonymous substitutions in GV oocytes and MII eggs, coinciding with an increase in ADAR1 protein (Fig 4a and Fig 1d) . Somatic tissues displayed a similar pattern to GV oocytes and MII eggs, which also express ADAR1 (Fig 4b) . To test if the increase in synonymous substitutions was a result of increased ADAR1 activity, we utilized RNA-seq data from a genetic mouse model expressing a catalytically inactive ADAR1, with a point mutation at E861A [35] . The prevalence of synonymous substitutions dramatically decreased in the E861A mutant, similar to PND12 oocytes, which also do not express ADAR1 (Fig 4b and Fig 1d) .
In order to predict the consequence of the amino acid substitutions, a computational tool, Sorting Intolerant From Tolerant (SIFT) that predicts the effects of amino acid substitution on protein function was used [36] . SIFT analysis showed that RNA edits observed in GV oocytes and MII eggs had increased levels of tolerated amino acid substitutions when compared to the PND12 oocytes (Fig 4c) . Similarly, somatic tissues exhibited a much greater level of tolerated (>80%) versus deleterious substitutions (Fig 4d) . In summary, ADAR1 editing is associated with increased tolerated, synonymous substitutions.
Selective editing at the wobble codon position
The abundance of RNA edit synonymous substitutions led us to investigate the potential effects of ADAR1 editing on codon usage. We first determined the number of A-to-I edits that occur in the 34 different codons that contain an adenosine, excluding stop codons. We found that in GV oocytes and MII eggs, RNA edits occur more frequently in the following codons: AAA, ACA, CAA, CCA, GAA, and GCA (Fig 5a; p<0 .05, two-way ANOVA). This effect was not due to a difference in the overall abundance of these codons (Supplemental Fig 5) . Further analysis indicated that adenosine deamination appeared to be specifically enriched at the wobble position (Fig 5b) . Even the AAA codon had a preference for RNA editing at the wobble position (Fig 5b) . This occurred predominantly in GV oocytes and MII eggs, rather than in PND12 oocytes, consistent with the lack of detectable ADAR1 in PND12 oocytes (Fig 5b and Fig 1d) .
We also examined this phenomenon in all 34 codons containing adenosines, and observed a similar pattern of increased RNA editing occurring at the wobble position (Fig 5c) and in somatic tissues (Fig 5d) . To test if RNA editing at the wobble position was due to ADAR1 catalytic activity, we compared brain tissues from wild-type mice with those of the ADAR1 E861A mutant.
The ADAR1 E861A mutant appears to have a similar profile as PND12 oocytes, which also lack ADAR1 protein (Fig 5d and Fig 1d) . Overall, ADAR1 activity was strongly associated with an RNA editing preference at the wobble position and this represents a novel ADAR1 signature.
RNA editing of codons and transcript stability
It has been demonstrated that codon usage can affect mRNA stability [32] . We examined the potential consequences of ADAR1 codon editing on mRNA stability. In order to gain insight into how specific codons might affect mRNA stability, we relied on observations that demonstrate GV oocytes and MII eggs are transcriptionally inactive [3, 37, 38] . Therefore, changes in transcript levels during the transition from GV oocytes to MII eggs are due to RNA stability rather than de novo RNA synthesis. Differential RNA abundance calculations during the transition from GV to MII can be interpreted as RNA stability measurements.
Differential RNA abundance within GV oocytes and MII eggs was determined, and 477 transcripts were stabilized and 628 transcripts were destabilized (Fig 6a) . From these transcripts, we determined the codon occurrence to mRNA stability correlation coefficient (CSC; [32] Fig 6b) . We found that six codons frequently edited by ADAR1 were associated with stable mRNA (Fig 5a and Fig 6b) . Moreover, editing within the codon would switch a stabilizing codon into a destabilizing one in three of these codons (Fig 6a) . For example, the most frequently ADAR1 edited codon is GAA (Fig 6a) , which is highly correlated with stable transcripts. If a GAA is hypothetically edited into GAG, it is then correlated with unstable transcripts (Fig 6b) . ADAR1 RNA editing could affect overall mRNA stability through editing of codons.
Discussion
Our studies provide a genome-wide analysis of the post-transcriptional modification, A-to-I RNA editing, at different stages of mouse oogenesis and maturation. We determined that ADAR1 codon editing exhibited preferential modification of the wobble position. Codons with ADAR1 edits at the wobble position were correlated with unstable mRNA. Analysis of our data demonstrates the presence of a novel regulatory process involving RNA modifications during oogenesis that have the potential to regulate translation and mRNA degradation.
During the growth phase of oogenesis, mammalian oocytes accumulate and store maternal RNA that are required to support the subsequent transcriptionally silent stages of meiotic maturation, fertilization, and early embryonic growth prior to embryonic genome activation [1] [2] [3] [38] [39] [40] . In fully grown GV oocytes and MII eggs, previously synthesized maternal mRNA are recruited into polysomes for translation [5, 41] . Maternal transcripts are subjected to translationally coupled degradation, and in the absence of degradation, maternal transcripts accumulate, resulting in embryonic arrest [5] . Thus, the regulatory roles of post-transcriptional and translational control at this stage of oogenesis are essential to ensure successful embryonic development. We observed very little Adar expression and no detectable protein in transcriptionally active PND12 oocytes. This correlated with a reduced overall number of edited transcripts, decreased proportion of edited transcriptome, and a reduced number of edits per transcript. In contrast, fully grown GV oocytes and transcriptionally quiescent MII eggs expressed abundant ADAR1 protein and have increased levels of mRNA editing.
A distinct RNA editing pattern was observed in mouse oocytes, with a majority of A-to-I edits occurring in the CDS and 3'UTR regions of transcripts. This is unique from a variety of other mouse somatic cell types (Fig 3c-d; [44] ), however, it is not unprecedented. Cephalopods have a high proportion of A-to-I RNA edits occurring in the CDS region of genes, and this has been hypothesized to increase proteome diversity and allow for increased adaptability [45] . A study of human oocytes identified a majority of A-to-I edits occurring in the 3'UTR regions (47.12 %), followed by intronic (33.77 %), non-coding RNA (17.12 %), and 5'-UTR regions (1.01 %), with only 0.98 % occurring in coding regions [46] . However, it is unclear if the increased coding region edits we have observed are due to species differences or due to the vitrification process and culture of human oocytes prior to sequencing, as described in the manuscript source of the oocyte sequencing data [47] . A recent cross-species analysis of RNA editing in somatic tissue revealed that species, rather than the type of tissue, was a greater source of RNA editing differences [6] . However, differences between oocytes and somatic post-transcriptional regulatory mechanisms are not unprecedented. For example, mouse oocytes express a unique isoform of Dicer, which favors endogenous siRNA biogenesis over miRNA biogenesis, that regulates the expression of retroelements [48] . It is possible that oocytes employ a unique A-to-I editing program necessary for steps in early embryonic development.
To understand the possible consequences of A-to-I editing within CDS regions of oocytes, we examined whether these edits cause nonsynonymous or synonymous substitutions within the mRNA. Our results indicate that GV oocytes and MII eggs, which have high levels of ADAR1 protein and A-to-I editing, have an increase in number of synonymous substitutions.
Synonymous substitutions are known to affect RNA transcript stability as well as translation efficiency because of codon availability and codon bias [49] . Of the codons with adenosines that have the potential to be edited, we observed that GV oocytes and MII eggs contained six codons that were edited at a significantly higher frequency than PND12 oocytes (Fig 5a) . These codons have a specific enrichment of RNA editing at the wobble position of the codon (Fig 5b) .
It should be noted that the increased appearance of certain edited codons was not a reflection of an overall increase in that codon within the mRNA transcripts present in oocytes (Supplemental Fig 5) . To test if the preferential RNA editing of the wobble position was dependent on ADAR1 activity, we compared the editing profiles of brain tissue from wild-type mice to those of mice expressing an ADAR1 E861A mutation that eliminates enzymatic activity [50] . We observed that mice expressing the ADAR1 E861A mutation displayed significantly reduced editing at the wobble position. This indicates that the wobble position A-to-I substitution is regulated by ADAR1.
No current models of ADAR1 function explain the enrichment of A-to-I editing at the wobble position; however, it is not unprecedented that RNA editing can occur at specific codon positions. Mitochondrial genes of the slime mold Physarum polycephalum also have an increase in RNA edits occurring at the third codon position [51, 52] . P. polycephalum mitochondrial RNA undergoes editing in the form of cytidine insertions at the third position of codons. In another example of RNA editing affecting codon usage, Arabidopsis and other plants exhibit deaminated cytidine bases primarily in the first two codon positions [53] [54] [55] . Although both of these examples involve a different type of RNA editing than ADAR A-to-I editing, they provide a antecedence for a link between RNA editing and codon position preference. In vitro models using purified ADAR1 and synthetic RNA have demonstrated that ADAR1 has a trinucleotide preference and specifically edits the second nucleotide of the triplet [56] . However, our analysis of codon editing using in vivo genetic models of catalytically inactive ADAR1 demonstrate that within the CDS, ADAR1 frequently edits the wobble position of codons. Most studies of ADAR editing do not focus on the CDS, and therefore this bias for editing the wobble position has gone undetected. Overall, our analysis produces RNA editing data that is consistent with previously reported editing profiles in somatic tissue. It is possible that mRNA from transcriptionally quiescent oocytes is edited at the first and second position of a codon, but degraded rapidly, resulting in an increase of mRNA with edits at the wobble position. However, even in transcriptional active somatic cells we observe that ADAR1 edits occur more frequently at the wobble position. Only in the catalytic ADAR1 E816A mutant and PND12 oocytes that lack ADAR1 editing, do we observe a decrease in wobble position editing. Further experiment are needed to understand the molecular mechanisms governing selective editing of codon positions.
Conclusion
We identified extensive RNA editing within the coding region of genes and low intronic RNA editing in oocytes, contrasting with previously reported RNA editing profiles of mouse somatic tissues [44] and human oocytes [57] . Our study also demonstrates a previously unreported phenomenon of ADAR1 editing of the codon wobble position. The wobble position was edited at a higher frequency than any other position, and this was not an oocyte-specific phenomenon.
We hypothesize that a consequence of ADAR1 editing is the fine-tuning of codon optimization in all tissue types. We therefore suggest that RNA editing by ADAR1 can contribute to mRNA stability through altered codon usage.
Methods
GV oocyte and MII egg RNA-seq datasets used in this study
Wild-type GV oocytes and MII egg RNA-seq data was identified by searching the Gene Expression Omnibus and downloaded from the Short Read Archive using SRAdb [58] . Wild-type GV oocyte data was used from data set SRP057558 [59] . The authors of this study demonstrated high quality of isolated GV oocytes (fully grown, meiotic competence, successful nuclear envelope breakdown and polar body extrusion). Contemporary GV oocytes were used for RNA-seq [59] . Wild-type MII oocyte RNA-seq data was used from data sets SRP034543 [60] and SRP065556 [61] . These samples were used because the MII eggs were isolated in vivo , from oviducts. Control somatic tissue RNA-Seq data was obtained from SRP098702 [35] . Briefly, first strand and second strand cDNA synthesis was conducted and purified using Agencourt RNAClean XP beads ( Beckman Coulter, A63987). cDNA products were then amplified using SPIA amplification and purified using Qiagen MinElute Reaction Cleanup Kit (Cat# 28204). Amplified cDNA was then fragmented using a Covaris S2 Ultrasonicator, and digested using S1 Nuclease treatment. DNA was purified, end repaired, ligated to adaptors, and amplified. The resulting libraries were analyzed on a Bioanalyzer DNA Chip 1000. Fragment distribution was between 150-200 base pairs. RNA-seq was performed using single-end Illumina HiSeq 4000. This raw data has been deposited in SRA BioProject PRJNA434598, SRP133083.
Transcript abundance analysis
Sequence alignment and transcript abundance calculations for PND12 oocytes, GV oocyte, MII eggs, and mouse somatic tissues were performed by aligning raw RNA-seq reads against mus musculus (mm10) transcripts curated from RefSeq using Kallisto, and differential transcript abundance was calculated using Sleuth [62] [63] [64] . Commonly edited and expressed transcripts were identified by performing multiple comparisons between all the samples (PND12 = 3, GV = 3, MII = 7).
Identification of RNA edits and RNA edit consequence analysis Raw RNA-seq reads were mapped to the mus musculus reference genome, mm10, using HISAT2 [65] . RNA/DNA differences were called following the Genome Analysis Toolkit (GATK) RNA-Seq variant pipeline with modifications [33] . The program elprep was used to sort, mark duplicates, and index RNA-seq reads [66] . Known SNPs were filtered out using a database from 17 mouse strains maintained by dbSNP [67] . The resulting VCF files were filtered for A/G and T/C variants. Variants calls were stranded with A/G occuring on the sense strand and T/C occuring on the antisense strand [68] . VCF files were used as input for Ensembl Variant Effect Predictor (VEP) [34] . VEP was used to identify edited transcripts, categorize the location within the transcript, and consequence of edits on coding capacity. Only transcripts with TPM ≥ 1 were considered in analysis of editing consequences. R statistical computation software with the following packages was used to parse VEP output: sleuth, biomaRt, dplyr, plyr, AnnotationFuncs, org.Mm.eg.db, ggplot2 [69] [70] [71] .
Validation of identified A-to-I RNA edits Total RNA was isolated by TRIzol extraction of GV oocytes collected from wild-type PMSG stimulated C57B/6J female mice and treated with DNase I (Thermo Fisher, AM2222). cDNA was generated using Superscript III (Thermo Fisher, 18080044) and Oligo dT 20 primers (Thermo Fisher, 18418020). Genomic DNA (gDNA) was isolated from tail clip of wild-type C57B/6J mice using REDExtract-N-Amp™ Tissue PCR Kit, (SigmaAldrich, XNAT-100RXN. gDNA and cDNA were amplified using Phusion® High-Fidelity DNA Polymerase (NEB, M0530). PCR reactions were purified using AMPure XP (Beckman Coulter, A63987) bead purification and cloned using the Zero Blunt™ TOPO™ PCR Cloning Kit (Thermo Fisher, K286020). Transformations were grown on LB+Kanamycin at 37 o C overnight. Individual colonies were picked and grown in liquid culture, LB+Kanamycin, overnight at 37 o C. Plasmid DNA was extracted from liquid culture using
QIAprep Spin Miniprep Kit (Qiagen, 27104). Individual clones were Sanger sequencing using M13 Fwd and M13 Rev primers at GeneWiz (Boston, MA). All primers used for cloning and sequencing are listed in Supplemental Table 1 .
Western blot analysis
Western blots were performed on groups of 30 oocytes (PND12, GV, and MII eggs) isolated from untreated PND12 and from day 21 wild-type C57/B6J females stimulated with PMSG. MII eggs were in vitro matured by removal of milrinone (2.5 µM) for 16 hours. Eggs with visible polar bodies were used for analysis. Groups of 30 oocytes or eggs were lysed directly in SDS sample buffer with 5% β-mercaptoethanol, and subjected to electrophoresis using 10% SDS-PAGE in 
Statistics
Statistical analyses were performed using R and Prism 7.0. Results of multiple repeats were presented as means ± SEM. Bartlett's tests were done to ensure equal variance among treatment groups. If data was normally distributed parametric tests were used. If data showed a variance outside of normal, the non-parametric test were used to determine if statistical differences existed. In cases where only two treatment groups existed, differences were determined by a non-parametric, unpaired t-Test (Mann Whitney). To determine statistical differences between groups with more than two treatment groups, one-way analysis of variance 
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Primer Name Sequence
Rpa1 -F AAGTACCACTGGTGGCCAGA
Rpa1 -R GGCTAATTAATTGCTTTCCAGTT
Mdc1 -F CCTTCTCAGACCATCGAACAG
Mdc1 -R TGAAGTGAAATTCATAAAGCAAAAA Wdr37 -F TCACTGATGTTCCTTAGCTCCA Wdr37 -R AAATGCACTTTTCCCTCAAAAA
